NeuroDerm (NDRM) Takes Off on Promising Drug Trials
December 31, 2014 at 09:25 AM EST
Shares of Rehovot, Israel, based NeuroDerm Ltd. (NDRM) rocketed on Tuesday, against the backdrop of a generally lower day in stocks overall. NeuroDerm’s stock was up by a market-leading 193.53%, rising $11.96 per share, to close at $18.14, on volume of 41,008,653 shares. The company reported positive mid-stage trial results for its Parkinson’s disease candidate. Founded Read the full article... Read the rest of NeuroDerm (NDRM) Takes Off on Promising Drug Trials at InvestorGuide.com .